About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Glaxosmithkline Pharmaceuticals Ltd.
BSE Code
500660
ISIN Demat
INE159A01016
Book Value
128.02
NSE Code
GLAXO
Dividend Yield %
1.97
Market Cap
463918.42
P/E
49.24
EPS
55.61
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
16-Sep-2025
2730.05
2767.00
2727.00
2738.50
1040
2857876
15-Sep-2025
2775.05
2789.75
2740.00
2755.05
4135
11401377
12-Sep-2025
2855.70
2855.70
2757.85
2774.95
3189
8930582
11-Sep-2025
2851.25
2879.65
2819.70
2863.80
2460
7015032
10-Sep-2025
2821.60
2855.95
2801.80
2833.60
2119
5986918
09-Sep-2025
2810.25
2825.00
2780.50
2818.30
1599
4486216
08-Sep-2025
2804.00
2834.15
2759.00
2820.85
5148
14368949
05-Sep-2025
2863.75
2863.75
2764.00
2770.30
2265
6340258
04-Sep-2025
2784.65
2880.00
2756.00
2840.55
4397
12482561
03-Sep-2025
2740.00
2780.90
2700.50
2773.40
7576
20684857
02-Sep-2025
2899.90
2899.90
2738.40
2749.15
2447
6814784
01-Sep-2025
2790.05
2816.55
2764.05
2804.55
1593
4443022
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.